Letter to the Editor
Bone Marrow Transplantation (2008) 42, 769–771; doi:10.1038/bmt.2008.246; published online 11 August 2008
Using reduced intensity conditioning and HLA-identical sibling donors, antithymocyte globulin increases the risk of relapse, which can be overcome by a high stem cell dose
M Remberger1, J Mattsson1, B-M Svahn1 and O Ringdén1
1Department of Clinical Immunology Centre for Allogeneic Stem Cell Transplantation and Clinical Immunology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Correspondence: M Remberger, E-mail: Mats.Remberger@ki.se
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Allogeneic stem cell transplantation as treatment for myelofibrosis
Bone Marrow Transplantation Review
RESEARCH
Bone Marrow Transplantation Original Article
Bone Marrow Transplantation Original Article
Bone Marrow Transplantation Original Article
Allogeneic stem cell transplantation: low immunoglobulin levels associated with decreased survival
Bone Marrow Transplantation Original Article

